CyPep-1

DRUG3 trials

Sponsors

Centre for Human Drug Research, Netherlands, Cytovation AS

Conditions

Advanced Breast CancerAdvanced Head and Neck Squamous Cell CarcinomaAdvanced MelanomaAdvanced Solid Tumor MalignancyCutaneous Warts

Phase 1

CyPep-1 in Cutaneous Warts

CompletedNCT03846648

Centre for Human Drug Research, NetherlandsCutaneous Warts

Start: 2019-03-11End: 2019-12-20Updated: 2021-08-03

CyPep-1 Injections in Cancer Inducing Lymphocyte Infiltrate Accumulations

CompletedNCT04260529

Cytovation ASAdvanced Solid Tumor Malignancy

Start: 2020-04-30End: 2024-07-05Updated: 2026-01-29

A Study to Evaluate the Safety and Efficacy of CyPep-1 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic Cancers

CompletedNCT05383170

Cytovation ASAdvanced Breast Cancer, Advanced Head and Neck Squamous Cell Carcinoma, Advanced Melanoma

Start: 2023-03-21End: 2024-09-23Updated: 2025-11-28

Related Papers

Quad-shot-immunotherapy: quad-shot radiotherapy with pembrolizumab for advanced/recurrent head and neck cancer

Future Oncology2023-05-185 citations